341 related articles for article (PubMed ID: 32949079)
1. SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.
Jarmoliński T; Matkowska-Kocjan A; Rosa M; Olejnik I; Gorczyńska E; Kałwak K; Ussowicz M
Pediatr Transplant; 2021 Aug; 25(5):e13875. PubMed ID: 32949079
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia.
Oltolini C; Acerbis A; Orofino G; Racca S; Noviello M; Dispinseri S; Clementi N; Piemontese S; Xue E; Giglio F; Lupo Stanghellini MT; Diral E; Bruno A; Tassi E; Beretta V; Marzinotto I; Scarlatti G; Lampasona V; Ardemagni A; Sampaolo M; Bonini C; Corti C; Peccatori J; Castagna A; Ciceri F; Greco R
Front Immunol; 2023; 14():1184956. PubMed ID: 37287986
[TBL] [Abstract][Full Text] [Related]
3. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
[TBL] [Abstract][Full Text] [Related]
6. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.
Seo S; Campbell AP; Xie H; Chien JW; Leisenring WM; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2013 Apr; 19(4):589-96. PubMed ID: 23298855
[TBL] [Abstract][Full Text] [Related]
7. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
[TBL] [Abstract][Full Text] [Related]
8. Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.
Campbell AP; Chien JW; Kuypers J; Englund JA; Wald A; Guthrie KA; Corey L; Boeckh M
J Infect Dis; 2010 May; 201(9):1404-13. PubMed ID: 20350162
[TBL] [Abstract][Full Text] [Related]
9. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
10. Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Mori T; Nakamura Y; Kato J; Yamane A; Aisa Y; Takeshita K; Okamoto S
Int J Hematol; 2011 Jan; 93(1):132-4. PubMed ID: 21207211
[No Abstract] [Full Text] [Related]
11. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group.
Bozkurt C; Hazar V; Malbora B; Küpesiz A; Aygüneş U; Fışgın T; Karakükçü M; Kuşkonmaz B; Kılıç SÇ; Bayırlı D; Arman Bilir Ö; Yalçın K; Gözmen S; Uygun V; Elli M; Sarbay H; Küpesiz FT; Şaşmaz Hİ; Aksoy BA; Yılmaz E; Okur FV; Tekkeşin F; Yenigürbüz FD; Özek G; Atay AA; Bozkaya İO; Çelen S; Öztürkmen S; Güneş AM; Gürsel O; Güler E; Özcan A; Çetinkaya DU; Aydoğdu S; Özbek NY; Karasu G; Sezgin G; Doğru Ö; Albayrak D; Öztürk G; Aksoylar S; Daloğlu H; Odaman Al I; Evim MS; Akbayram S; Öncül Y; Zengin E; Albayrak C; Timur Ç; Kar YD; Çakmaklı HF; Tüfekçi Ö; Töret E; Antmen B
Pediatr Transplant; 2024 May; 28(3):e14758. PubMed ID: 38659218
[TBL] [Abstract][Full Text] [Related]
12. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
Peck AJ; Corey L; Boeckh M
Clin Infect Dis; 2004 Sep; 39(5):673-80. PubMed ID: 15356782
[TBL] [Abstract][Full Text] [Related]
13. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
Renaud C; Xie H; Seo S; Kuypers J; Cent A; Corey L; Leisenring W; Boeckh M; Englund JA
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1220-6. PubMed ID: 23680472
[TBL] [Abstract][Full Text] [Related]
14. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
16. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children.
Jiang S; Liu P; Xiong G; Yang Z; Wang M; Li Y; Yu XJ
Clin Chem Lab Med; 2020 Jun; 58(7):1160-1161. PubMed ID: 32301747
[No Abstract] [Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP; Lu DP; Wu DP; Jiang EL; Liu DH; Huang H; Sun ZM; Li NN; Liu QF; Zhang X; Lai YR; Song YP; Song XM; Liu SX; Zhang YC; Luo CJ; Xia LH; Niu T; Yu Y; Zhang XH; Tang XW; Luo Y; Huang XJ;
Transplant Cell Ther; 2023 Feb; 29(2):136.e1-136.e7. PubMed ID: 36402457
[TBL] [Abstract][Full Text] [Related]
18. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
20. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
